期刊文献+

肝功能异常为主要临床表现的噬血细胞综合征10例临床分析 被引量:4

The clinical analysis of hepatic dysfunction caused by hemophagocytic syndrome of 10 cases
下载PDF
导出
摘要 目的通过对10例以肝功能异常为主要临床表现的噬血细胞综合征病例进行分析,探讨本病的临床特点,提高对本病的认识。方法对10例患者的病史、临床表现和实验室检查结果进行综合分析。结果噬血细胞综合征(HPS)可表现为严重的肝功能损害,其特点为胆红素明显升高,以直接胆红素升高为主,以及ALT、AST及GGT升高。结论不明原因肝功能异常并伴有发热和血细胞减少的患者应警惕HPS,早期诊断和治疗。 Objective To investigate the clinical features of hepatic dysfunction caused by hemophagocytic syndrome(HPS).Methods Medical records,clinical manifestations and laboratory findings were analyzed.Results Characteristics of hepatic dysfunction caused by hemophagocytic syndrome were increase of direct bilirubin level,and increase of alanine aminotransferase(ALT),aspartate aminotransferase(AST) and γ-glutamyltransferase(GGT).Conclusion Awareness of diagnosis of HPS is crucial when patients have unknown hepatic dysfunction,fever,hepatosplenomegaly and pancytopenia.
出处 《临床肝胆病杂志》 CAS 2011年第2期189-191,共3页 Journal of Clinical Hepatology
关键词 淋巴组织细胞增多症 嗜血细胞性 肝功能试验 lymphohistiocytosis hemophagocytic liver funetion teses
  • 相关文献

参考文献7

二级参考文献17

  • 1Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr, 2007 ; 166 : 95 - 109
  • 2Fautrel B, Le Moel G, Saint Marcoux B, et al. Diagnostic value of ferritin and glyeosylated fenitin in adult onset Still′s disease. J Rheumatol, 2001,28:322-329
  • 3Henter JI, Home AC, Arico M, et al. HLH-2004: diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistioeytosis. Pediatr Blood Cancer, 2007 ; 48 : 124 - 131
  • 4Vignes S, Le-Moel G, Fautrel B, et al. Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Stills disease. Ann Rheum Dis, 2000 ; 59 : 347 - 350
  • 5Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 2008; 50:1227 -1235
  • 6Yamashita N, Oba K, Nakano H, et al. Age-related changes in concentrations of ferritin, glyeosylated ferritin, and non-glycosylated ferritin. Nippon Ronen Igakkai Zasshi, 1996; 33:754 -760
  • 7Chandra P, Chaudhery SA, Rosener F, et al. Transient histocytosis with striking phagocytosis of platelets, leukocytes and erythrocytes. Arch Intern Med, 1975; 135:989 -991
  • 8Janka G, Zur Stadt U. Familial and acquired hemophagocytic lym- phohistiocytosis. Hematology Am Soc Hematol Educ Program, 2005 : 82 - 88
  • 9Janka G, Imashuku S, Elinder G, et al. Infection and malignancy- associated hemophagocytic syndromes. Hematol Oncol Clin Nonrth Am, 1998; 12:435-444
  • 10Henter JI, Home AC, Arico M, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis, Pediatr Blood Cancer 2007 ;48:124 - 131

共引文献46

同被引文献41

  • 1王淑娟.对恶性组织细胞病诊断的再认识[J].中华检验医学杂志,2005,28(1):14-16. 被引量:15
  • 2Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis [J]. Eur J Pediatr, 2007, 166(2): 95-109.
  • 3Henter JI, Home A, Aric6 M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2007, 48 (2): 124-131.
  • 4Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan [J]. Int J Hematol, 2007, 86(1): 58-65.
  • 5Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis,macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? [J]. Arthritis Rheum, 2004, 50 (3): 689-698.
  • 6Greenberger PA. Immunologic and cystic fibrosis [J]. JAMAaspects of lung diseases 1997, 278 (22): 1924- 1930.
  • 7Ravelli A, Magni-Manzoni S, Pistorio A, et al. Pre- liminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis [J]. J Pediatr, 2005, 146(5): 598-604.
  • 8Kumakura S, Ishikura H, Kondo M, et al. Autoimmune- associated hemophagocytic syndrome [J]. Mod Rheumatol, 2004, 14(3): 205-215.
  • 9Bielekova B, Catalfamo M, Reichert-Scrivner S, et al. Regulatory CD56 (bright) natural killer cells mediate immunomodulatory effects of IL-2Rct-targeted therapy (daclizumab) in multiple sclerosis [J]. Proc Natl Acad Sci USA, 2006, 103(15): 5941-5946.
  • 10Okamoto M, Yamaguchi H, Isobe Y, et al. Analysis of triglyeeride value in the diagnosis and treatment response of secondary hemophagocytie syndrome [J]. Intern Med, 2009, 48(10): 775-781.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部